Results 101 to 110 of about 527,356 (286)

The outcomes of electronic personal health records in patients with heart failure or coronary artery disease

ESC Heart Failure, Volume 12, Issue 2, Page 1464-1468, April 2025.
Abstract Background There are limited data on the efficacy of smartphone‐based personal health records (PHRs) in patients with cardiovascular disease. This study aimed to examine the processes, outcomes and challenges associated with the implementation of integrated PHRs in patients with heart failure (HF) or coronary artery disease (CAD). Methods This
Kotaro Nochioka, Satoshi Yasuda, Takashi Shiroto, Saori Yamamoto, Haruka Sato, Yuhi Hasebe, Shigeo Godo, Makoto Nakano, Tomohiko Shindo, Kensuke Nishimiya, Kiyotaka Hao, Jun Takahashi, Keisuke Ido, Yoichi Kakuta, Hiroaki Shimizu, Hiroaki Shimokawa, Masaharu Nakayama   +16 more
wiley   +1 more source

Therapeutic potential of nicorandil beyond anti-anginal drug: A review on current and future perspectives

Heliyon
Nicorandil (NIC) is a well-known anti-anginal agent, which has been recommended as one of the second-line treatments for chronic stable angina as justified by the European guidelines. It shows an efficacy equivalent to that of classic anti-anginal agents.
Dhirendra Singh, Randhir Singh, Abidemi James Akindele   +2 more
doaj   +1 more source

A rare case of spontaneous and simultaneous multivessel coronary artery spasm leading to multisite myocardial infarction and ventricular fibrillation

ARYA Atherosclerosis, 2018
BACKGROUND: Coronary artery spasm (CAS) can result in life-threatening arrhythmia and sudden cardiac death. Although this disorder has been known for a long time, little is known about it, and its mechanisms have been not identified yet.CASE REPORT: We ...
Leili Iranirad, Mohammad Saleh Sadeghi
doaj   +1 more source

Thallium-201 uptake in variant angina: probable demonstration of myocardial reactive hyperemia in man.

, 1982
Myocardial thallium scintigraphy was performed in four subjects with variant angina and in one subject with isolated, fixed coronary obstruction. Three subjects with variant angina had short episodes of ischemic ST-segment elevation that lasted 20--100 ...
D Robertson, R M Robertson, M L Born, R A Steckley, G C Friesinger, M W Kronenberg   +5 more
core   +1 more source

Study protocol: a randomised controlled trial investigating the effect of exercise training on peripheral blood gene expression in patients with stable angina [PDF]

, 2010
Background: Exercise training has been shown to reduce angina and promote collateral vessel development in patients with coronary artery disease. However, the mechanism whereby exercise exerts these beneficial effects is unclear.
David C Crossman, Tew, G.A., Chico, Timothy, Tew, Garry, Bourke, Liam, John M Saxton, Tew, Garry A., Milo, M., Saxton, John, Liam Bourke, Garry A Tew, Saxton, John M, Saxton, J.M., Milo, Marta, Crossman, D.C., Chico, Timothy J. A., Marta Milo, Saxton, John M., Crossman, David C, Chico, Timothy JA, Chico, TJA, Crossman, David C., Saxton, JM, Milo, M, Crossman, DC, Crossman, David, Timothy JA Chico, Chico, T.J.A., Bourke, L., Saxton John M, Crossman David C, Milo Marta, Chico Timothy JA, Tew Garry A, Bourke Liam   +34 more
core   +2 more sources

The in‐hospital administration of sacubitril/valsartan in acute myocardial infarction: A meta‐analysis

ESC Heart Failure, Volume 12, Issue 2, Page 998-1012, April 2025.
In patients with Acute Myocardial Infarction related heart failure, the in‐hospital administration of ARNIs was associated with a reduced risk of MACEs and re‐hospitalizations for heart failure, as well as cardiac remodeling, compared to standard therapy.
Gianluca Di Pietro, Riccardo Improta, Paolo Severino, Andrea D'Amato, Lucia Ilaria Birtolo, Ovidio De Filippo, Antonio Lattanzio, Raffaele De Cristofaro, Giacchino Galardo, Fabrizio D'Ascenzo, Roberto Badagliacca, Gennaro Sardella, Maurizio Volterrani, Francesco Fedele, Carmine Dario Vizza, Massimo Mancone   +15 more
wiley   +1 more source

Idiopathic Effusive-Constrictive Pericarditis Presented by Variant Angina. [PDF]

Cureus, 2021
Adachi K, Hayashi T, Omatsu T, Hirayama A, Higuchi Y.   +4 more
europepmc   +1 more source

A rare cause of cardiogenic shock: Variant angina [PDF]

, 2014
Variant angina (VA) is a clinical syndrome caused by spontaneous vasospasm of the epicardial coronary artery which is characterized by episodes of angina. Endothelial dysfunction and neurohormonal hyperactivity are important factors in pathogenesis of VA.
SÜNBÜL, MURAT, YEŞİLDAĞ, OSMAN
core   +1 more source

Considerations for drug trials in hypertrophic cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1095-1112, April 2025.
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant, Matthias Schmitt, Anna B. Reid, Clifford J. Garratt, William G. Newman, Aneil Malhotra, Rhys Beynon, Masliza Mahmod, Betty Raman, Robert M. Cooper, Dana Dawson, Thomas Green, Sanjay K. Prasad, Anvesha Singh, Susanna Dodd, Hugh Watkins, Stefan Neubauer, Christopher A. Miller   +17 more
wiley   +1 more source

Vasospastic angina: a review on diagnostic approach and management

Therapeutic Advances in Cardiovascular Disease
Vasospastic angina (VSA) refers to chest pain experienced as a consequence of myocardial ischaemia caused by epicardial coronary spasm, a sudden narrowing of the vessels responsible for an inadequate supply of blood and oxygen. Coronary artery spasm is a
Kenny Jenkins, Graziella Pompei, Nandine Ganzorig, Sarah Brown, John Beltrame, Vijay Kunadian   +5 more
doaj   +1 more source